Terms: = Head and neck cancer AND TFG, TF6, 10342, ENSG00000114354, Q92734 AND Prognosis
8 results:
1. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
[TBL] [Abstract] [Full Text] [Related]
2. Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.
Starska K; Forma E; Jóźwiak P; Lewy-Trenda I; Danilewicz M; Stasikowska-Kanicka O; Skóra M; Kolary K; Miazga J; Krześlak A; Bryś M
Tumour Biol; 2016 Oct; 37(10):13185-13203. PubMed ID: 27456359
[TBL] [Abstract] [Full Text] [Related]
3. The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
Starska K; Forma E; Nowacka-Zawisza M; Lewy-Trenda I; Ciesielski P; Pietruszewska W; Skóra M; Bryś M
Tumour Biol; 2016 Apr; 37(4):4541-57. PubMed ID: 26503213
[TBL] [Abstract] [Full Text] [Related]
4. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
[TBL] [Abstract] [Full Text] [Related]
5. Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.
Starska K; Forma E; Brzezińska-Błaszczyk E; Lewy-Trenda I; Bryś M; Jóźwiak P; Krześlak A
Clin Exp Med; 2015 Nov; 15(4):455-68. PubMed ID: 25315705
[TBL] [Abstract] [Full Text] [Related]
6. [Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma].
Lukomski M; Lewy-Trenda I; Stasikowska O; Durko M; Starska K
Otolaryngol Pol; 2007; 61(5):805-10. PubMed ID: 18552024
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of matrix metalloproteinases type I expression and tumor front parameters in the presence of lymph node micrometastases in carcinoma of the larynx.
Starska K; Łukomski M; Stasikowska O; Lewy-Trenda I
Adv Med Sci; 2007; 52():169-73. PubMed ID: 18217412
[TBL] [Abstract] [Full Text] [Related]
8. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
[TBL] [Abstract] [Full Text] [Related]
